These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 7561688)

  • 1. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies.
    Khare SD; Luthra HS; David CS
    J Exp Med; 1995 Oct; 182(4):1153-8. PubMed ID: 7561688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-B27 transgenic mice are susceptible to collagen-induced arthritis: type II collagen as a potential target in human disease.
    Lee S; Khare SD; Griffiths MM; Luthra HS; David CS
    Hum Immunol; 2000 Feb; 61(2):140-7. PubMed ID: 10717806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m.
    Khare SD; Hansen J; Luthra HS; David CS
    J Clin Invest; 1996 Dec; 98(12):2746-55. PubMed ID: 8981920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arthritis in HLA-B27 transgenic animals.
    Taurog JD
    Am J Med Sci; 1998 Oct; 316(4):250-6. PubMed ID: 9766486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New aspects in the pathogenesis of Bechterew disease].
    Märker-Hermann E; Sucké B; Meyer zum Büschenfelde KH
    Z Rheumatol; 1996; 55(1):4-18. PubMed ID: 8868146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out mice.
    Khare SD; Luthra HS; David CS
    Semin Immunol; 1998 Feb; 10(1):15-23. PubMed ID: 9529652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide binding alpha1alpha2 domain of HLA-B27 contributes to the disease pathogenesis in transgenic mice.
    Khare SD; Lee S; Bull MJ; Hanson J; Luthra HS; Hammerling GJ; David CS
    Hum Immunol; 1999 Feb; 60(2):116-26. PubMed ID: 10027779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
    Kollnberger S; Bird LA; Roddis M; Hacquard-Bouder C; Kubagawa H; Bodmer HC; Breban M; McMichael AJ; Bowness P
    J Immunol; 2004 Aug; 173(3):1699-710. PubMed ID: 15265899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absence of human beta 2-microglobulin increases the occurrence of ankylosing enthesopathy in HLA-B27 transgenic mice.
    Chopin M; Plichtova R; Urbero B; Pla M
    Clin Rheumatol; 1996 Jan; 15 Suppl 1():28-31. PubMed ID: 8835498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders.
    Hammer RE; Maika SD; Richardson JA; Tang JP; Taurog JD
    Cell; 1990 Nov; 63(5):1099-112. PubMed ID: 2257626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides.
    Khare SD; Bull MJ; Hanson J; Luthra HS; David CS
    J Immunol; 1998 Jan; 160(1):101-6. PubMed ID: 9551961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment.
    Breban M; Hammer RE; Richardson JA; Taurog JD
    J Exp Med; 1993 Nov; 178(5):1607-16. PubMed ID: 8228809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.
    Taurog JD; Maika SD; Simmons WA; Breban M; Hammer RE
    J Immunol; 1993 May; 150(9):4168-78. PubMed ID: 8473755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B27 transgenic rats model.
    Breban M
    Ann Med Interne (Paris); 1998 Apr; 149(3):139-41. PubMed ID: 11490535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of spontaneous arthritis in beta2-microglobulin-deficient mice without expression of HLA-B27: association with deficiency of endogenous major histocompatibility complex class I expression.
    Kingsbury DJ; Mear JP; Witte DP; Taurog JD; Roopenian DC; Colbert RA
    Arthritis Rheum; 2000 Oct; 43(10):2290-6. PubMed ID: 11037889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.
    Tran TM; Dorris ML; Satumtira N; Richardson JA; Hammer RE; Shang J; Taurog JD
    Arthritis Rheum; 2006 Apr; 54(4):1317-27. PubMed ID: 16575857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous inflammatory disease in HLA-B27 transgenic mice does not require transporter of antigenic peptides.
    Khare SD; Lee S; Bull MJ; Hanson J; Luthra HS; David CS
    Clin Immunol; 2001 Mar; 98(3):364-9. PubMed ID: 11237560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin.
    Bertrand V; Quéré S; Guimbaud R; Sogni P; Chauvelot-Moachon L; Tulliez M; Lamarque D; Charreire J; Giroud JP; Couturier D; Chaussade S; Breban M
    Eur Cytokine Netw; 1998 Jun; 9(2):161-70. PubMed ID: 9681392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of HLA-B27-associated diseases: new outcomes.
    Hacquard-Bouder C; Ittah M; Breban M
    Joint Bone Spine; 2006 Mar; 73(2):132-8. PubMed ID: 16377230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B27 transgenic rats: animal model of human HLA-B27-associated disorders.
    O'Neill TP
    Toxicol Pathol; 1997; 25(4):407-8. PubMed ID: 9280126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.